Related Experiment Video
Updated: Mar 16, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
New gold carbene complexes as candidate anticancer agents
Alessandro Pratesi1, Damiano Cirri1, Mirjana D Đurović2
1(MetMed) Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019, Sesto Fiorentino, Italy.
Abstract:
Three structurally related gold(I) carbene complexes with bulky hydrophobic ligands i.e. 1-3 were investigated in solution for further consideration as candidate anticancer agents. Cytotoxic assays were subsequently conducted on bone marrow-derived preosteoclast cell line of human origin (FLG 29.1) and human colon cancer cells (HCT-116). A far greater cytotoxic activity was measured for compound 1 against HCT-116 cells compared to 2 and 3; conversely, all compounds were highly and similarly active against FLG 29.1 cells. Results obtained for the reaction of complexes 1 and 2 with RNase A documented the occurrence of a weak interaction with this model protein and the formation of a tiny amount of the corresponding adduct. Moreover, a certain reactivity of the complex 2 was also detected toward GSH. The general implications of the obtained results are discussed.
Insights
Three gold(I) carbene complexes were evaluated as anticancer agents. Compound 1 showed higher activity against colon cancer cells, while all compounds were active against preosteoclast cells, suggesting potential therapeutic applications.
Area of Science:
- Medicinal Chemistry
- Inorganic Chemistry
- Cancer Biology
Background:
- Gold(I) complexes are explored for anticancer properties.
- Bulky hydrophobic ligands influence complex behavior and efficacy.
- Understanding structure-activity relationships is crucial for drug development.
Purpose of the Study:
- To investigate the anticancer potential of three novel gold(I) carbene complexes.
- To compare the cytotoxic activity of these complexes against human colon cancer and preosteoclast cell lines.
- To explore the interactions of these complexes with biomolecules like RNase A and glutathione.
Main Methods:
- Synthesis and characterization of gold(I) carbene complexes 1-3.
- In vitro cytotoxic assays using human colon cancer (HCT-116) and preosteoclast (FLG 29.1) cell lines.
- Biochemical assays to study interactions with Ribonuclease A (RNase A) and glutathione (GSH).
Main Results:
- Compound 1 exhibited significantly higher cytotoxicity against HCT-116 cells compared to compounds 2 and 3.
- All three complexes demonstrated high and similar activity against FLG 29.1 cells.
- Weak interactions were observed between complexes 1 and 2 with RNase A, forming minimal adducts.
- Complex 2 showed reactivity towards GSH.
Conclusions:
- The investigated gold(I) carbene complexes display differential cytotoxic activities, with compound 1 being particularly effective against colon cancer cells.
- The complexes show promise as anticancer agents, especially for targeting preosteoclast cells.
- Further studies are warranted to elucidate the precise mechanisms of action and optimize their therapeutic potential.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...

